Canopy Growth Corp (CGC)
$7.32
0.88 (10.73%)
CGC Stock Quote Delayed 30 Minutes
Embrace the Recent Strength in Canopy Growth Stock
CGC stock is up a whopping 75% in 2019 alone, and yet Canopy Growth is still just scratching the surface of its long term potential.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
4.29B
PE Ratio
-104.57
EPS
-0.07
Volume (Avg. Vol.)
5.47M
Day's Range
$7.20 - $8.09
52-Week Range
$2.76 - $19.20
Dividend & Yield
N/A (N/A)
CGC Stock Predictions, Articles, and Canopy Growth Corp News
Cannabis-Infused Drinks Are a Slow Burn for NBEV Stock
NBEV stock hasn't raced higher like pot stocks have following recent cannabis-based news, but New Age Beverages is still well-positioned.
Why Canopy Growth’s Arrival in the U.S. Will Be Huge for CGC Stock
The 2018 Farm Bill followed by a New York State hemp license are two big steps for CGC stock on its path towards a $100 billion valuation.
InvestorPlace Roundup: The Top Stocks in the Market Today, Including CGC Stock
InvestorPlace's financial journalists, analysts and advisors discuss the top stocks and the worst, shining a light on what to buy and sell.
Canopy Growth News: CGC Stock Surges on NY Hemp License
In the latest Canopy Growth news, CGC stock is surging more than 13% on Monday as the company garnered a license to produce hemp in New York.
3 Reasons People Are Getting Excited About Buying CGC Stock
It’s been a wild ride for Canopy Growth stock. But this looks like an opportunity for investors, especially those with a long-term perspective. CGC looks to be one of the best positioned to benefit from the fast-growing market for cannabis.
Nope, It’s Not Yet Time to Buy Canopy Growth
Canopy Growth stock has rallied sharply in recent days. But these key factors will snuff out the rally in CGC stock in coming weeks.
1.1 Million Reasons Why You Should Buy Constellation Stock
Constellation Brands stocks has been decimated, but there is opportunity. Bet with the former STZ stock CEO's 1.1 million new shares.
Thursday’s Vital Data: Canopy Growth, Micron and Ford
Options trading was buzzing in Canopy Growth Corp, Micron and Ford Wednesday. Here are the metrics that matter moving forward.
Should You Buy Constellation Brands Stock After Its Earnings Plunge?
Constellation Brands earnings are not helping the stock, with STZ stock down about 10% after reporting third-quarter results.
Canopy Growth Stock: 3 Pros, 3 Cons
Both speculators and skeptics should consider the various catalysts and pitfalls for Canopy Growth stock.
Reality Starts to Rain on Canopy Growth Stock
CGC stock was red-hot just a few months ago, but the hype machine can only prop Canopy Growth shares up for so long.
Why Canopy Growth Stock Should Be in Your Sights
Of the whole bunch, CGC stock is the one to buy. This is a long-term bet and Canopy Growth will shrug this Wall Street malaise soon enough.
Canopy Growth Stock Investors Should Focus On The Forest, Not The Trees
Canopy Growth's a leader in a secular growth market with huge potential. That means CGC stock could ultimately turn into a multi-bagger for investors.
Aphria Stock Investors Balk At the Fine Print of Green Growth’s Offer
Aphria stock may be up on the heels of Green Growth Brands' offer, but it's still a relatively disappointing deal for APHA stock investors.
Is CGC Stock All Hype or Opportunity?
CGC stock is risky by nature, but as marijuana stocks go Canopy Growth looks like a good option to play the trend.
This Is the Best Way to Approach Cronos Stock Today
CRON stock should be on your radar as a trade, not a buy-and-hope investment. Here's what investors need to know about Cronos.
Why Aphria Stock Isn’t the Kind of Pot Stock to Hold Forever
The euphoric rise in Aphria stock is history after increased bearishness, thanks to investor scrutiny over an acquisition, has beaten APHA down.
Is Tilray Stock a Must-Buy Following New Partnership?
Tilray stock is still very expensive, even after its partnership with Novartis' Sandoz. However, TLRY is in a very tradable range.
